The impact of strict COVID-19 lockdown in Spain on glycemic profiles in patients with type 1 Diabetes prone to hypoglycemia using standalone continuous glucose monitoring

التفاصيل البيبلوغرافية
العنوان: The impact of strict COVID-19 lockdown in Spain on glycemic profiles in patients with type 1 Diabetes prone to hypoglycemia using standalone continuous glucose monitoring
المؤلفون: Irene Pueyo, Ignacio Conget, Daria Roca, Mercè Vidal, Clara Viñals, Alex Mesa, Marga Giménez
المصدر: Diabetes Research and Clinical Practice
بيانات النشر: Elsevier BV, 2020.
سنة النشر: 2020
مصطلحات موضوعية: Blood Glucose, Male, Endocrinology, Diabetes and Metabolism, State Medicine, 0302 clinical medicine, Endocrinology, Insulin, Longitudinal Studies, 030212 general & internal medicine, education.field_of_study, Continuous glucose monitoring, Insulin, Short-Acting, General Medicine, Middle Aged, Insulin, Long-Acting, Female, Coronavirus Infections, Adult, medicine.medical_specialty, Coronavirus disease 2019 (COVID-19), Pneumonia, Viral, Population, Monitoring, Ambulatory, 030209 endocrinology & metabolism, Hypoglycemia, Article, Injections, Betacoronavirus, 03 medical and health sciences, Blood Glucose Self-Monitoring, Diabetes mellitus, medicine, Internal Medicine, Humans, Hypoglycemic Agents, education, Pandemics, Retrospective Studies, Glycemic, Type 1 diabetes, SARS-CoV-2, business.industry, COVID-19, Retrospective cohort study, medicine.disease, Diabetes Mellitus, Type 1, Spain, Communicable Disease Control, Emergency medicine, Observational study, COVID-19 lockdown, standalone continuous glucose monitoring, business, type 1 diabetes mellitus
الوصف: Aims Spain has been one of the worst affected countries by the COVID-19 pandemic. A very strict lockdown at home was imposed with a tough restriction of mobility. We aimed to evaluate the impact of this exceptional scenario on glucose profile of patients with T1D prone to hypoglycemia using standalone continuous glucose monitoring. Methods Patients with T1D prone to hypoglycemia using multiple daily injections and either a Dexcom G5® or a Free Style Libre® CGM systems for at least 6 months under the funding of National Health Service were included in an observational, retrospective study. Data were collected in two periods: pre-lockdown (PL), February 23rd-March 7th and within lockdown (WL), April 1st-14th 2020. The primary outcome was the difference in the proportion of time in target glucose range of 70–180 mg/dL (TIR). Additional glucometric data were also analysed. Results 92 patients were included: 40 women, age 42.8±3.9 years, disease duration of 23.1±12.6 years. Seventeen patients used Dexcom G5® and 75 Free Style Libre®. TIR 70–180 mg/dL (59.3±16.2 vs 62.6±15.2%), time >180 (34.4±18.0 vs 30.7±16.9%), >250 (11.1±10.6 vs 9.2 ± 9.7%) and Glucose Management Indicator (7.2±0.8 vs 7.0±0.8%) significantly improved (PL vs WL, respectively, p
اللغة: English
تدمد: 0168-8227
DOI: 10.1016/j.diabres.2020.108354
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1a9f27fa6a0b7e95ffe64a46ac31c6cTest
حقوق: OPEN
رقم الانضمام: edsair.doi.dedup.....b1a9f27fa6a0b7e95ffe64a46ac31c6c
قاعدة البيانات: OpenAIRE
الوصف
تدمد:01688227
DOI:10.1016/j.diabres.2020.108354